Read end-to-end by a FundingAtlas editor against the official source.
Quick answer
NIHR Research for Patient Benefit (RfPB) is a UK funding programme. England-based researchers in NHS, social care, and partner organisations leading patient-benefit research. Funding: Up to £500k. Frontline NHS and care teams conducting applied research. It is published as a standard listing — verify current rounds and full criteria on the official source before applying.
Funding amount
Up to £500k
Region
England
Stage
Growth
Provider
National Institute for Health and Care Research
Frequently asked questions
- Who is NIHR Research for Patient Benefit (RfPB) for?
- Frontline NHS and care teams conducting applied research.
- How much funding is available through NIHR Research for Patient Benefit (RfPB)?
- Funding is Up to £500k. Exact amounts depend on project scope, eligibility, and the live call. Always confirm current figures on the official provider page before applying.
- How long does the NIHR Research for Patient Benefit (RfPB) application take?
- Timelines vary by call. Plan for several weeks between starting the application and a funding decision, and longer where panel review, due diligence, or subsidy-control checks apply.
- What are the main alternatives to NIHR Research for Patient Benefit (RfPB)?
- Consider other National Institute for Health and Care Research programmes, options on the Innovation Funding Pathway, and adjacent routes discussed in our KTP vs Innovate UK Smart Grants comparison.
- What happens after a successful NIHR Research for Patient Benefit (RfPB) application?
- Successful applicants sign a funding agreement, complete onboarding, and report against agreed milestones. Use the award to build the evidence base for follow-on funding once the project delivers measurable outcomes.
- What are the most common mistakes when applying for NIHR Research for Patient Benefit (RfPB)?
- Weak fit with the stated objectives, vague impact metrics, missing match funding, and applying before the business is operationally ready are the most common reasons applications stall or are rejected.
Who it's for
Frontline NHS and care teams conducting applied research.
Usually too early when
Advisor signal
Apply before you can clearly articulate the project scope, evidence of fit with National Institute for Health and Care Research's priorities, and a credible delivery plan. Businesses earlier than the growth stage typically struggle to evidence the operational thresholds assessors look for.
Eligibility
England-based researchers in NHS, social care, and partner organisations leading patient-benefit research.
Common reasons applications fail
Reasons applications fail or stall: • Weak fit with the stated objectives of the scheme. • Vague impact claims without named metrics, baselines or timing. • Match funding not secured at the point of application. • Project plan that reads like business-as-usual rather than additional, new activity. • Insufficient evidence the team has delivered comparable work before. • Late engagement — applying close to deadline without internal sign-off.
What improves your odds
Strong alignment with National Institute for Health and Care Research's published priorities. A specific, measurable project with named deliverables and timelines. Evidence the team can deliver — relevant prior projects, named technical leads, and secured (not hoped-for) match funding where required. Clear quantified impact: jobs, productivity, exports, emissions reduction or commercial outcomes appropriate to the scheme.
Typical successful applicant
A UK-based organisation that already meets the eligibility criteria for NIHR Research for Patient Benefit (RfPB) on paper, has prior delivery experience relevant to National Institute for Health and Care Research, and can evidence the stated impact within the funding window.
Common misconceptions
That NIHR Research for Patient Benefit (RfPB) is a quick or guaranteed source of capital. It is not — assessment is competitive and most applicants are unsuccessful. That a strong application can be drafted in days; in practice, competitive submissions take weeks of preparation, evidence gathering, and internal sign-off.
What comes next
On a successful award: deliver against the agreed milestones, build the evidence base for follow-on funding (commercial pilots, larger grants, debt or equity), and document outcomes that strengthen the next application. On rejection: request feedback, address the specific weaknesses, and consider an adjacent scheme on the Innovation Funding Pathway before re-applying.
Funding context
NIHR Research for Patient Benefit (RfPB) sits within National Institute for Health and Care Research's wider funding remit. Treat it as one option on the Innovation Funding Pathway; the right route depends on stage, project type and what comes next commercially. Use it alongside, not instead of, complementary support.
Related routes
- Arts Council Project Grants
- Accelerated Growth Programme
- Enterprise Investment Scheme (EIS)
- Innovate UK EDGE (Legacy Advisory Service)
- Innovation Funding Pathway
- Scale-Up Funding Pathway
- KTP vs Innovate UK Smart Grants
- Regional Funding vs National Funding
- Am I too early for Innovate UK?
- How to fund deep tech
Industries
Objectives
Regions